Lawsuit against Celgene, BMS and others moves forward

25-04-2023

Liz Hockley

Lawsuit against Celgene, BMS and others moves forward

IgorGolovniov / Shutterstock.com

New Jersey judge denies motion to stay antitrust action regarding blockbuster cancer drug | Defendants had argued litigation would be unnecessary and costly.


Celgene, Bristol Myers-Squibb, Natco, Teva, Revlimid, antitrust

LSIPR